<b>Background:</b> Congenital disorder of glycosylation (CDG) is a severe morphogenic and metabolic disorder that affects all of the systems of organs and is caused by a mutation of the gene <i>PMM2</i>, having a mortality rate of 20% during the first months of life. Here, PMM2 is linked to metabolic disease.